Akero Therapeutics, Inc. Comprehensive Income
Akero Therapeutics, Inc. reported Comprehensive Income of -$80.73 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2025-11-07
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$80.73M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$70.60M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$70.59M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-12-31 was -$71.18M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$251.38M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$151.53M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$111.97M.
- Akero Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$100.80M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$80.73M 10-Q · filed 2025-11-07 | -$151.33M derived: sum of 2 quarters · filed 2025-11-07 | -$221.92M 10-Q · filed 2025-11-07 | -$293.10M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-06-30 | -$70.60M 10-Q · filed 2025-08-08 | -$141.19M 10-Q · filed 2025-08-08 | -$212.37M derived: sum of 3 quarters · filed 2025-08-08 | -$282.71M derived: sum of 4 quarters · filed 2025-11-07 |
| 2025-03-31 | -$70.59M 10-Q · filed 2025-05-12 | -$141.77M derived: sum of 2 quarters · filed 2025-05-12 | -$212.11M derived: sum of 3 quarters · filed 2025-11-07 | -$268.28M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-12-31 | -$71.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$141.52M derived: sum of 2 quarters · filed 2025-11-07 | -$197.69M derived: sum of 3 quarters · filed 2025-11-07 | -$251.38M 10-K · filed 2025-02-28 |
| 2024-09-30 | -$70.34M 10-Q · filed 2025-11-07 | -$126.51M derived: sum of 2 quarters · filed 2025-11-07 | -$180.20M 10-Q · filed 2025-11-07 | -$234.61M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$56.17M 10-Q · filed 2025-08-08 | -$109.86M 10-Q · filed 2025-08-08 | -$164.27M derived: sum of 3 quarters · filed 2025-08-08 | -$204.19M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$53.69M 10-Q · filed 2025-05-12 | -$108.10M derived: sum of 2 quarters · filed 2025-05-12 | -$148.02M derived: sum of 3 quarters · filed 2025-05-12 | -$179.37M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | -$54.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$94.32M derived: sum of 2 quarters · filed 2025-02-28 | -$125.68M derived: sum of 3 quarters · filed 2025-02-28 | -$151.53M 10-K · filed 2025-02-28 |
| 2023-09-30 | -$39.91M 10-Q · filed 2024-11-08 | -$71.27M derived: sum of 2 quarters · filed 2024-11-08 | -$97.12M 10-Q · filed 2024-11-08 | -$120.14M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$31.36M 10-Q · filed 2024-08-09 | -$57.20M 10-Q · filed 2024-08-09 | -$80.22M derived: sum of 3 quarters · filed 2025-02-28 | -$115.76M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$25.85M 10-Q · filed 2024-05-10 | -$48.87M derived: sum of 2 quarters · filed 2025-02-28 | -$84.41M derived: sum of 3 quarters · filed 2025-02-28 | -$111.78M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$23.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$58.56M derived: sum of 2 quarters · filed 2025-02-28 | -$85.94M derived: sum of 3 quarters · filed 2025-02-28 | -$111.97M 10-K · filed 2025-02-28 |
| 2022-09-30 | -$35.54M 10-Q · filed 2023-11-13 | -$62.91M derived: sum of 2 quarters · filed 2023-11-13 | -$88.95M 10-Q · filed 2023-11-13 | -$121.38M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$27.38M 10-Q · filed 2023-08-11 | -$53.41M 10-Q · filed 2023-08-11 | -$85.84M derived: sum of 3 quarters · filed 2024-02-29 | -$110.18M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$26.03M 10-Q · filed 2023-05-15 | -$58.47M derived: sum of 2 quarters · filed 2024-02-29 | -$82.80M derived: sum of 3 quarters · filed 2024-02-29 | -$111.74M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$32.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$56.77M derived: sum of 2 quarters · filed 2024-02-29 | -$85.71M derived: sum of 3 quarters · filed 2024-02-29 | -$100.80M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$24.34M 10-Q · filed 2022-11-04 | -$53.28M derived: sum of 2 quarters · filed 2022-11-04 | -$68.37M 10-Q · filed 2022-11-04 | -$98.10M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | -$28.94M 10-Q · filed 2022-08-05 | -$44.03M 10-Q · filed 2022-08-05 | -$73.76M derived: sum of 3 quarters · filed 2022-08-05 | -$95.24M derived: sum of 4 quarters · filed 2022-08-05 |
| 2021-03-31 | -$15.09M 10-Q · filed 2022-05-06 | -$44.82M derived: sum of 2 quarters · filed 2022-05-06 | -$66.30M derived: sum of 3 quarters · filed 2022-05-06 | -$82.46M derived: sum of 4 quarters · filed 2022-05-06 |
| 2020-12-31 | -$29.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$51.21M derived: sum of 2 quarters · filed 2022-02-25 | -$67.37M derived: sum of 3 quarters · filed 2022-02-25 | -$79.20M 10-K · filed 2022-02-25 |
| 2020-09-30 | -$21.48M 10-Q · filed 2021-11-12 | -$37.64M derived: sum of 2 quarters · filed 2021-11-12 | -$49.47M 10-Q · filed 2021-11-12 | -$65.09M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | -$16.16M 10-Q · filed 2021-08-13 | -$28.00M 10-Q · filed 2021-08-13 | -$43.61M derived: sum of 3 quarters · filed 2022-02-25 | -$59.17M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | -$11.84M 10-Q · filed 2021-05-13 | -$27.45M derived: sum of 2 quarters · filed 2022-02-25 | -$43.01M derived: sum of 3 quarters · filed 2022-02-25 | -$50.23M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | -$15.62M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$31.17M derived: sum of 2 quarters · filed 2022-02-25 | -$38.40M derived: sum of 3 quarters · filed 2022-02-25 | -$43.76M 10-K · filed 2022-02-25 |
| 2019-09-30 | -$15.55M 10-Q · filed 2020-11-12 | -$22.78M derived: sum of 2 quarters · filed 2020-11-12 | -$28.14M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$7.23M 10-Q · filed 2020-08-12 | -$12.59M 10-Q · filed 2020-08-12 | ||
| 2019-03-31 | -$5.36M 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | -$81.71M 10-K · filed 2020-03-16 |